Share

J&J CEO: Our science is well-positioned to deal with variants

"The great news is the agility, the flexibility that we have to actually literally be designing software real time to help address of some of these new and emerging variants," Johnson & Johnson CEO Alex Gorsky told CNBC's "Squawk Box" on Monday. "We're quite confident based upon the clinical data that we already have with our vaccine that we're going to see a very robust response," he said.
04:40
Mon, Mar 1 20218:51 AM EST